In addition, endometrial adenocarcinoma patients expressed significantly higher levels of MCL-1 and lower levels of BAK and BAX, whereas BCL-xL and p21 levels did not significantly differ between the two groups (Fig. 6c). The gene discussed is BCL2L1; the disease is endometrium adenocarcinoma.